Partner
Gary Connors
Gary has over 25 years of experience working in the chemical and pharmaceutical industries, holding various senior positions, including Managing Director, before becoming a Partner at Oliver Wight. Gary brings a pragmatic and persistent approach to business development and believes that people are the key to driving business transformation.
As an Oliver Wight Partner, Gary is passionate about educating business leaders and inspiring organisations to push their ambitions further than they imagined. Drawing on his wealth of experience and expertise, Gary applies the latest methodologies in business planning to guide organisations in their journey to business excellence and Class A accreditation. By transferring knowledge and building in-house expertise, Gary installs sustainable changes in organisations and gives confidence to clients that they can deliver a world-class performance.
The most satisfying part of my job is when an organisation I’m working with truly starts to believe that they can be better than they ever imagined.Gary Connors, Partner at Oliver Wight
Resources
The latest from Gary
Thought Piece
Future trends: biopharma to outpace small molecule drug development
Gary Connors looks at some of the most important factors that will affect the pharmaceutical industry going forward.
Gary Connors
Partner
White Papers
Healing Healthcare – Future-proofing your master data
At Oliver Wight we have a recurring scenario that plays out with many of our healthcare clients. It starts with their unshakeable belief that their data is accurate; ‘it must be, right? We are in a highly regulated industry after all’. The next act is an academic exercise to measure the data, quickly followed by utter horror when the level of inaccuracy is revealed. After a period of inactivity comes denial; the explanations as to why ‘the data can never be as accurate as other industries.’ Then acceptance sets in and action to improve begins.
Gary Connors
Partner
Join our newsletter
Sign up to our newsletter for updates, insights and news straight to your inbox.
